Common Contracts
5 similar Letter Agreement contracts by Xenetic Biosciences, Inc.
October 11, 2017 James E. Callaway, Ph.D 4893 Drakewood Terrace San Diego, CA 92130 Dear James:Letter Agreement • March 30th, 2018 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Letter Agreement (the "Agreement") is to confirm the terms of your proposed appointment on August 14, 2017 (the "Effective Date") as a non-employee, independent Director of Xenetic Biosciences, Inc. (the "Company").
October 11, 2017Letter Agreement • March 30th, 2018 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Letter Agreement (the “Agreement”) is to confirm the terms of your proposed appointment on August 14, 2017 (the “Effective Date”) as a non-employee, independent Director of Xenetic Biosciences, Inc. (the “Company”).
Xenetic Biosciences, Inc. Ledgemont Research Ctr Hayden Avenue Lexington, MA 02421 United States t 781-778-7722 e info@xeneticbio.comLetter Agreement • November 22nd, 2016 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Letter Agreement (the “Agreement”) is to confirm the terms of your proposed appointment on November 18 2016 (the “Effective Date”) as a non-employee Director of Xenetic Biosciences, Inc. (the “Company”).
Xenetic Biosciences, Inc.Ledgemont Research Ctr Hayden Avenue Lexington, MA 02421 United States t 781-778-7722 e info@xeneticbio.comLetter Agreement • July 12th, 2016 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Letter Agreement (the “Agreement”) is to confirm the terms of your proposed appointment on July 8, 2016 (the “Effective Date”) as a non-employee, independent Director of Xenetic Biosciences, Inc. (the “Company”).
Xenetic Biosciences, Inc. Ledgemont Research Ctr Hayden Avenue Lexington, MA 02421 United States t 781-778-7722 e info@xeneticbio.comLetter Agreement • February 29th, 2016 • Xenetic Biosciences, Inc. • Pharmaceutical preparations
This Letter Agreement (the “Agreement”) is to confirm the terms of your proposed appointment on February 2016 (the “Effective Date”) as a non-employee, independent Director of Xenetic Biosciences, Inc. (the “Company”).
